Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mycobacterium tuberculosis F1Fo ATP synthase subunit c (AtpE) is a vital component of the bacterial energy-generating complex, forming a rotor ring (c-ring) within the Fo sector of the enzyme (Preiss et al., 2015, PNAS). This c-ring facilitates the transport of protons across the plasma membrane, converting the electrochemical gradient into mechanical rotation that drives ATP synthesis in the F1 sector (Koul et al., 2007, Nat. Chem. Biol.). As Mycobacterium tuberculosis is an obligate aerobe that depends on oxidative phosphorylation for survival, the ATP synthase is essential for both actively replicating and dormant bacilli (Andries et al., 2005, Science). The diarylquinoline drug bedaquiline (Sirturo) targets this specific subunit by binding to a conserved pocket, effectively locking the c-ring and preventing the rotation necessary for ATP production (Preiss et al., 2015, PNAS). This inhibition leads to a rapid decline in intracellular ATP levels and subsequent bacterial death, making it a cornerstone in the treatment of multi-drug resistant tuberculosis (MDR-TB) (Mahajan, 2013, Int. J. App. Basic Med. Res.). While highly effective, the use of drugs targeting this site requires monitoring for potential side effects such as QTc interval prolongation and liver toxicity (Cohen, 2013, Science). The high selectivity of bedaquiline for the mycobacterial c-ring over the human mitochondrial counterpart is due to specific sequence differences in the binding pocket, which minimizes off-target effects (Haagsma et al., 2009, Antimicrob. Agents Chemother.).
Bedaquiline and its analogs bind to the c-subunit of the Fo rotor, physically obstructing the rotation of the c-ring and blocking the proton-pumping mechanism required for ATP synthesis (Andries et al., 2005, Science; Preiss et al., 2015, PNAS).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis F1Fo ATP synthase subunit c (AtpE).